{"prompt": "['Abbreviated Title: Ph II SGI110 in Peds & Adults', '8', 'Version Date: 07/22/2019', '9.1', 'Comprehensive Adverse Event and Potential Risk List (CAEPRs)', '38', '9.1.1', 'Comprehensive Adverse Events and Potential Risks list (CAEPR for SGI-110', '(NSC 780463)', '38', '9.2', 'Adverse Event Characteristics', '42', '9.3', 'Expedited Adverse Event Reporting to CTEP', '42', '9.3.1', 'Expedited AE reporting', '42', '9.3.2', 'Distribution of Adverse Event Reports', '43', '9.3.3', 'Expedited Reporting Guide lines', '43', '9.4', 'Routine Adverse Event Reporting to CTEP', '44', '9.5', 'Secondary Malignancy', '44', '9.6', 'Second Malignancy', '45', '10 NIH Intramural Research Program Reporting', '45', '10.1', 'Definitions', '45', '10.2', 'OHSRP Office of Compliance and Training/ IRB Reporting', '45', '10.2.1', 'Expedited Reporting', '45', '10.2.2', 'IRB Requirements for PI Reporting at Continuing Review', '45', '10.3', 'NCI Clinical Director Reporting', '45', '11', 'STUDY OVERSIGHT AND DATA REPORTING/REGULATORY REQUIREMENTS', '45', '11.1', 'Study Oversight', '45', '11.2', 'Data Reporting', '46', '11.2.1', 'Method', '46', '11.3', 'Data Sharing Plans', '47', '11.3.1', 'Human Data Sharing Plan', '47', '11.3.2', 'Genomic Data Sharing Plan', '47', '12', 'STATISTICAL CONSIDERATIONS', '47', '13 COLLABORATIVE AGREEMENTS', '48', '14 HUMAN SUBJECTS PROTECTIONS', '49', '14.1', 'Rationale For Subject Selection', '49', '14.1.1 Gender and Minority Accrual Estimates', '49', '14.2', 'Participation of Children', '50', '14.3', 'Participation of Subjects Unable to Give Consent', '50', '14.4', 'Evaluation of Benefits and Risks/Discomforts', '51', '14.4.1', 'Risks of SGI-110', '51', '14.5', 'Risks/Benefits Analysis', '51']['Abbreviated Title: Ph II SGI110 in Peds & Adults', '9', 'Version Date: 07/22/2019', '14.6', 'Consent and Assent Process and Documentation', '51', '14.6.1', 'Consent for minors when they reach the age of majority', '52', '14.6.2', 'Telephone consent', '53', '15 PHARMACEUTICAL INFORMATION', '53', '15.1 SGI-110 (Guadecitabine) (NSC 780463)', '53', '15.1.1 Agent Ordering and Agent Accountability', '55', '15.1.2 Incompatibilities', '56', '16 APPENDICES', '57', '16.1', 'Appendix I-Performance Status Criteria', '57', '16.2', 'Appendix II: Performance Status Scales/Scores in Patients 16 years of age', '58', '16.3', 'Appendix III: Quality of Life Tools', '59', '16.3.1', 'Pediatric PROMIS Instruments English (6)', '59']['Abbreviated Title: Ph II SGI110 in Peds & Adults', '10', 'Version Date: 07/22/2019', '16.3.2', 'Pediatric PROMIS Instruments Spanish (6)', 'PROMIS Pediatric v.1.1 - Depressive Symptoms - Short Form 8b', 'S\u00edntomas de depresi\u00f3n en pediatr\u00eda - Cuestionario abreviado 8b', 'Responde a cada enunciado marcando una casilla por l\u00ednea.', 'En los \u00faltimos 7 d\u00edas', 'Nunca', 'Casi nunca', 'A veces', 'A menudo', 'Casi siempre', 'No pude dejar de', 'sentirme triste.', '0', '1', '2', '3', '4', '4B1R1', 'Senti que estaba solo/a.', '0', '1', '2', '3', '4', '5041R1', 'Senti que todo me sal\u00eda', 'mal en la vida.', '0', '1', '2', '3', '4', '5035R1', 'Senti que no pod\u00eda hacer', 'nada bien.', '0', '1', '2', '3', '4', '711R1', 'Me senti solo/a.', '0', '1', '2', '3', '4', '226R1', 'Me senti triste.', '0', '1', '2', '3', '4', '71281', 'Me senti descontento/a.', '0', '1', '2', '3', '4', 'Me result\u00f3 dif\u00edcil', 'divertirme.', '0', '1', '2', '3', '4', 'Spanish (Universal)', '27 January 2014', 'c 2009-2013 PROMIS Health Organization and PROMIS Cooperative Group', '65', '16.3.3', 'Paralle 1 Parent Proxy PROMIS Instruments English (6)', '71', '16.3.4', 'Adult Patient PROMIS Instruments English (6)', '77']\n\n###\n\n", "completion": "END"}